226 related articles for article (PubMed ID: 20300113)
1. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
Harr MW; Caimi PF; McColl KS; Zhong F; Patel SN; Barr PM; Distelhorst CW
Cell Death Differ; 2010 Sep; 17(9):1381-91. PubMed ID: 20300113
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
McCaig AM; Cosimo E; Leach MT; Michie AM
Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B
Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.
Schade AE; Schieven GL; Townsend R; Jankowska AM; Susulic V; Zhang R; Szpurka H; Maciejewski JP
Blood; 2008 Feb; 111(3):1366-77. PubMed ID: 17962511
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids.
Petrillo MG; Fettucciari K; Montuschi P; Ronchetti S; Cari L; Migliorati G; Mazzon E; Bereshchenko O; Bruscoli S; Nocentini G; Riccardi C
BMC Pharmacol Toxicol; 2014 Jul; 15():35. PubMed ID: 24993777
[TBL] [Abstract][Full Text] [Related]
6. Lck is a key target of imatinib and dasatinib in T-cell activation.
Lee KC; Ouwehand I; Giannini AL; Thomas NS; Dibb NJ; Bijlmakers MJ
Leukemia; 2010 Apr; 24(4):896-900. PubMed ID: 20147973
[No Abstract] [Full Text] [Related]
7. Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.
Harr MW; Rong Y; Bootman MD; Roderick HL; Distelhorst CW
J Biol Chem; 2009 Nov; 284(46):31860-71. PubMed ID: 19776014
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
Laukkanen S; Veloso A; Yan C; Oksa L; Alpert EJ; Do D; Hyvärinen N; McCarthy K; Adhikari A; Yang Q; Iyer S; Garcia SP; Pello A; Ruokoranta T; Moisio S; Adhikari S; Yoder JA; Gallagher K; Whelton L; Allen JR; Jin AH; Loontiens S; Heinäniemi M; Kelliher M; Heckman CA; Lohi O; Langenau DM
Blood; 2022 Oct; 140(17):1891-1906. PubMed ID: 35544598
[TBL] [Abstract][Full Text] [Related]
9. Superantigen-induced steroid resistance depends on activation of phospholipase Cβ2.
Verhaar AP; Wildenberg ME; Duijvestein M; Vos AC; Peppelenbosch MP; Löwenberg M; Hommes DW; van den Brink GR
J Immunol; 2013 Jun; 190(12):6589-95. PubMed ID: 23690479
[TBL] [Abstract][Full Text] [Related]
10. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
Nerreter T; Distler E; Köchel C; Einsele H; Herr W; Seggewiss-Bernhardt R
Exp Hematol; 2013 Jul; 41(7):604-614.e4. PubMed ID: 23466625
[TBL] [Abstract][Full Text] [Related]
11. Lck Inhibits Heat Shock Protein 65-Mediated Reverse Cholesterol Transport in T Cells.
Luo T; Hu J; Xi D; Xiong H; He W; Liu J; Li M; Lu H; Zhao J; Lai W; Guo Z
J Immunol; 2016 Nov; 197(10):3861-3870. PubMed ID: 27742830
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.
Huber S; Oelsner M; Decker T; zum Büschenfelde CM; Wagner M; Lutzny G; Kuhnt T; Schmidt B; Oostendorp RA; Peschel C; Ringshausen I
Leukemia; 2011 May; 25(5):838-47. PubMed ID: 21293487
[TBL] [Abstract][Full Text] [Related]
14. Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.
Song Z; Lu P; Furman RR; Leonard JP; Martin P; Tyrell L; Lee FY; Knowles DM; Coleman M; Wang YL
Clin Cancer Res; 2010 Jan; 16(2):587-99. PubMed ID: 20068106
[TBL] [Abstract][Full Text] [Related]
15. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.
Mestermann K; Giavridis T; Weber J; Rydzek J; Frenz S; Nerreter T; Mades A; Sadelain M; Einsele H; Hudecek M
Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270272
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN.
Löwenberg M; Verhaar AP; Bilderbeek J; Marle Jv; Buttgereit F; Peppelenbosch MP; van Deventer SJ; Hommes DW
EMBO Rep; 2006 Oct; 7(10):1023-9. PubMed ID: 16888650
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck.
Ghosh MC; Baatar D; Collins G; Carter A; Indig F; Biragyn A; Taub DD
Blood; 2009 Jan; 113(3):575-84. PubMed ID: 18840710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
